Athanasios Pallis - Concepedia

Author

Athanasios Pallis

Also Known As

A G Pallis, A Pallis, A. G. Pallis, A. Pallis, A.G. Pallis, Athanasios G Pallis, Athanasios G. Pallis, Athanasios Pallis, S Oerlemans, S. Oerlemans

151

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Heraklion University of Crete Hellenic Oncology Research Group European Organisation for Research and Treatment of Cancer The Netherlands Cancer Institute

About

Athanasios Pallis is an author at University Hospital of Heraklion specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.6K
2	Health Sciences	7	7	597
3	Public Health	1	1	60
4	Cell Biology	1	1	50
5	Emergency Medicine	1	1	30

Athanasios Pallis

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article Hans Wildiers, Murielle Mauer, Athanasios Pallis, Journal of Clinical Oncology Cancer ManagementClinical EndpointEpidemiology Of CancerCancer RegistrationGeriatric Medicine	2013	320
Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology Athanasios Pallis, Cesare Gridelli, Ulrich Wedding, Annals of Oncology Palliative CareGeriatric OncologyOncologyElderly PatientsGeriatrics	2014	182
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors Athanasios Pallis, Alexander Ring, Catherine Fortpied, Annals of Oncology Geriatric OncologyGeriatricsMedicineEortc WorkshopCancer Management	2011	153
Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece Athanasios Pallis, Ioannis G. Vlachonikolis, Ioannis Mouzas BMC Gastroenterology	2002	95
‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer Athanasios Pallis, Alexandra Voutsina, Ar Kalikaki, British Journal of Cancer Kinase InhibitorsPathologyCancer BiologyTumor BiologyClassical Exon	2007	92
Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance Stella Apostolaki, Maria Perraki, Athanasios Pallis, Annals of Oncology Breast OncologyMedicineImmunologyAdjuvant ChemotherapyPathology	2007	82
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer N. Xenidis, V. Markos, Stella Apostolaki, Annals of Oncology Breast OncologyMedicineImmunologyClinical RelevancePathology	2007	73
Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial John Souglakos, Athanasios Pallis, Stylianos Kakolyris, Oncology	2005	62
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer Ioannis Gioulbasanis, Athanasios Pallis, Panagiotis J. Vlachostergios, Lung Cancer Metastatic Lung CancerPrognostic BiomarkersPrognostic EvaluationMedicineCancer Management	2012	61
Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis Zoe Giannousi, Ioannis Gioulbasanis, Athanasios Pallis, Supportive Care in Cancer NutritionPsychiatryAcute Phase ResponseMedicineMood Symptom	2011	60

Page 1